Brightstar Capital Partners completed the acquisition of Analyte Health.

Brightstar Capital Partners, a private equity firm, completed the acquisition of Analyte Health, a technology-driven, direct-to-consumer digital health company. Financial terms were not disclosed. “This partnership marks an exciting new chapter for us, as Brightstar brings both strategic expertise and a deep respect for the culture and customer trust we’ve built. I’m confident Brightstar’s operational resources and investment will help us scale while staying true to our mission of providing accessible, high-quality care directly to the consumer. I’m proud to continue leading the Company forward and remain fully committed as a significant shareholder,” Fiyyaz Pirani, Analyte CEO.